Medication Monitoring Not Documented for Opioid, Diabetes, and Anticoagulant Therapy
Summary
The facility failed to ensure that three residents’ medication regimens were monitored for ordered side effects and signs or symptoms. The deficiency involved a resident receiving oxycodone with acetaminophen, a resident with diabetes receiving insulin, and a resident receiving apixaban. The record review and interviews showed that the ordered monitoring was not documented as required for these medications. For the resident receiving oxycodone with acetaminophen, the admission record showed diagnoses including fractures of the left humerus, pubis, and left acetabulum, rheumatoid arthritis, and pulmonary fibrosis. The H&P stated the resident had capacity to understand and make decisions, while the MDS showed moderate cognitive impairment and significant assistance needs with ADLs. During interviews, the resident reported abdominal pain and pressure and said the pain medication had not been relieving the discomfort. The MDSC reviewed the orders, monitoring records, and MAR and stated there was no documentation that the resident was monitored for adverse effects or side effects of oxycodone with acetaminophen, including constipation or respiratory depression. For the resident with diabetes, the admission record listed Type II DM with hyperglycemia, a foot ulcer, hypertension, and PVD. The H&P stated the resident did not have capacity to understand and make decisions, and the MDS showed mild cognitive impairment with dependence or assistance needed for multiple ADLs. Review of the monitoring record for two months showed no monitoring for hyperglycemia or hypoglycemia documented. The record also showed a COC note indicating hyperglycemia and an order summary directing monitoring for signs and symptoms of hypo- and hyperglycemia. For the resident receiving apixaban, the admission record listed atrial fibrillation, hypertension, and anxiety disorder. The H&P stated the resident had fluctuating capacity, and the MDS showed mild cognitive impairment with assistance needs. The order summary required monitoring for bleeding signs such as blood in urine or stool, bleeding from gums or nose, excessive wound bleeding, large hemorrhagic areas, and petechiae, but the monitoring record had blank documentation on several days during the day shift. The MDSC stated anticoagulants were monitored every day due to bleeding risk and that the blank entries should have been audited and corrected.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.